oa SA Pharmaceutical Journal - Montelukast in the treatment of asthma : review

Volume 81, Issue 1
  • ISSN : 2221-5875
  • E-ISSN: 2220-1017



Despite the ongoing development of treatment standards for asthma, many patients who suffer from this chronic disease do not receive optimal care. The emphasis of asthma treatment is to achieve control through an understanding of the pathophysiology and pharmacotherapy of this chronic condition. Leukotriene receptor antagonists are a class of drugs which act as controllers by exhibiting anti-inflammatory action. Updated treatment guidelines place emphasis on the use of anti-inflammatory medication as the foundation of asthma treatment. Therefore, leukotriene receptor antagonists have been positioned as maintenance treatment for adults and children with chronic asthma.

Loading full text...

Full text loading...


Article metrics loading...


This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error